查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813978

基于 CRISPR 的基因编辑市场规模、份额和趋势分析报告：按产品/服务、最终用途、地区和细分市场预测，2025 年至 2033 年

CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report By Product & Service (CRISPR Kits & Reagents), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

基于 CRISPR 的基因编辑市场摘要

预计 2024 年全球基于 CRISPR 的基因编辑市场价值将达到 40.1 亿美元，预计 2033 年将达到 135 亿美元，2025 年至 2033 年的复合年增长率为 14.7%。

这一增长是由遗传疾病的日益普及、研究和技术的进步、政府的支持措施以及对生物技术的投资增加所推动的。

CRISPR技术及应用的进展

CRISPR 技术和应用的进步显着加速了市场成长，提高了基因编辑的精确度、效率和多功能性。自发现以来，CRISPR-Cas 系统已从基本的 DNA 切割发展成为一个复杂的基因组工程平台。高保真度 Cas 突变体、碱基编辑、引子编辑以及脂质奈米颗粒和病毒载体等改进的递送机制等创新推动了 CRISPR-Cas 系统的发展。这些改进减少了脱靶效应，提高了编辑效率，并扩大了可治疗疾病的范围。与人工智慧 (AI) 和机器学习的结合进一步优化了嚮导 RNA 设计和目标位点选择，从而实现了更快、更准确的开发週期。此外，该技术的适应性支持多重编辑，能够同时修改多个基因，这对于解决复杂的疾病和性状至关重要。

这些进步使 CRISPR 从人类治疗扩展到新的应用领域，包括农业、工业生物技术、诊断和环境管理。在农业方面，CRISPR 正被用于创造适应气候、抗虫害和营养丰富的作物，为粮食安全挑战提供解决方案。在诊断方面，基于 CRISPR 的工具（如 SHERLOCK 和 FELUDA）能够快速且低成本地检测感染疾病。同时，在合成生物学方面，CRISPR 正被用于改造微生物以实现永续的生质燃料和物质生产。 CRISPR 应用范围的不断扩大，加上持续的技术进步，正在吸引製药公司、农业生物技术公司和研究机构的大量投资。这种持续的创新循环扩大了潜在市场，并加强了 CRISPR 作为跨多个产业变革性技术平台的地位。

目录

第一章调查方法与范围

第二章执行摘要

3. 基于 CRISPR 的基因编辑市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场前景。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 基于CRISPR的基因编辑市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

4.基于CRISPR的基因编辑市场：产品和服务估计和趋势分析

  • 细分仪表板
  • 全球基于CRISPR的基因编辑市场产品与服务波动分析
  • 2021 年至 2033 年全球基于 CRISPR 的基因编辑市场规模及趋势分析（按产品和服务）
  • 产品
    • CRISPR套件和试剂
    • CRISPR文库
    • 其他的
  • 服务

第五章基于 CRISPR 的基因编辑市场：应用估计和趋势分析

  • 细分仪表板
  • 全球CRISPR基因编辑市场应用差异分析
  • 2021-2033 年全球 CRISPR 基因编辑市场规模及应用趋势分析
  • 生物医学
    • 治疗进展
    • 疾病诊断
  • 农业用途
    • 工厂工程
    • 畜牧工程
    • 其他的

6. 基于 CRISPR 的基因编辑市场：最终用途预估与趋势分析

  • 细分仪表板
  • 全球基于 CRISPR 的基因编辑市场最终用途变异分析
  • 2021-2033 年全球基于 CRISPR 的基因编辑市场规模和趋势分析（按最终用途）
  • 製药和生物技术公司
  • 学术研究机构
  • 合约研究组织

7. 基于 CRISPR 的基因编辑市场：区域估计和趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2021-2033年：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Tocris Bioscience
    • OriGene Technologies, Inc.
    • Bio-Rad Laboratories
    • Bio-Techne
    • New England Biolabs, Inc.
Product Code: GVR-4-68040-468-8

CRISPR-based Gene Editing Market Summary

The global CRISPR-based gene editing market size was estimated at USD 4.01 billion in 2024 and is projected to reach USD 13.50 billion by 2033, growing at a CAGR of 14.7% from 2025 to 2033. This growth is driven by the rising prevalence of genetic disorders, advancements in research and technology, supportive government initiatives, and increasing investment in biotechnology.

Advancements in CRISPR Technology & Applications

Advancements in CRISPR technology and applications are significantly accelerating market growth by enhancing precision, efficiency, and versatility in gene editing. Since its discovery, the CRISPR-Cas system has evolved beyond basic DNA cutting into a sophisticated genome engineering platform. It is supported by innovations such as high-fidelity Cas variants, base editing, prime editing, and improved delivery mechanisms such as lipid nanoparticles and viral vectors. These improvements have reduced off-target effects, increased editing efficiency, and broadened the scope of treatable conditions. Integration with artificial intelligence (AI) and machine learning has further optimized guide RNA design and target site selection, enabling faster, more accurate development cycles. Technology's adaptability also supports multiplexed editing, allowing simultaneous modification of multiple genes crucial for tackling complex diseases and traits.

These advancements also expand CRISPR into new application areas beyond human therapeutics, including agriculture, industrial biotechnology, diagnostics, and environmental management. In agriculture, CRISPR is being applied to create climate-resilient, pest-resistant, and nutrient-enhanced crops, offering solutions to food security challenges. In diagnostics, CRISPR-based tools such as SHERLOCK and FELUDA enable rapid, low-cost detection of infectious diseases. At the same time, in synthetic biology, CRISPR is used to engineer microorganisms for sustainable biofuel and material production. The widening scope of CRISPR applications, coupled with ongoing technical refinements, is attracting strong investments from pharmaceutical companies, agri-biotech firms, and research institutions. This continual innovation cycle expands the addressable market and strengthens CRISPR's position as a transformative technology platform across multiple industries.

Global CRISPR-based Gene Editing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global CRISPR-based gene editing market based on product & service, application, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • CRISPR Kits & Reagents
    • CRISPR Libraries
    • Others
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biomedical
    • Therapeutic Development
    • By Indication
    • Genetic Disorders
    • Oncology
    • Ophthalmology
    • Others
    • By Delivery Method
    • Ex Vivo
    • In Vivo
    • Disease Diagnostics
  • Agricultural applications
    • Plant Engineering
    • Farm Animals Engineering
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of genetic disorders
      • 3.2.1.2. Growing investments in biotechnology and healthcare research
      • 3.2.1.3. Advancements in CRISPR technology and applications
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Ethical concerns surrounding gene editing
      • 3.2.2.2. High costs associated with CRISPR research and development
  • 3.3. CRISPR-based Gene Editing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
  • 4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. CRISPR Kits & Reagents
      • 4.4.2.1. CRISPR kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. CRISPR Libraries
      • 4.4.3.1. CRISPR libraries market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
  • 5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Biomedical
    • 5.4.1. Biomedical market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Therapeutic Development
      • 5.4.2.1. Therapeutic development market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.2. By Indication
        • 5.4.2.2.1. Genetic Disorders
          • 5.4.2.2.1.1. Genetic Disorders market estimates and forecasts 2021 to 2033 (USD Million)
        • 5.4.2.2.2. Oncology
          • 5.4.2.2.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
        • 5.4.2.2.3. Ophthalmology
          • 5.4.2.2.3.1. Ophthalmology market estimates and forecasts 2021 to 2033 (USD Million)
        • 5.4.2.2.4. Others
          • 5.4.2.2.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.3. By Delivery Method
        • 5.4.2.3.1. Ex Vivo
          • 5.4.2.3.1.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million
        • 5.4.2.3.2. In Vivo
          • 5.4.2.3.2.1. In vivo market estimates and forecasts 2021 to 2033 (USD Million
    • 5.4.3. Disease Diagnostics
      • 5.4.3.1. Disease diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Agricultural applications
    • 5.5.1. Agricultural applications market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. Plant Engineering
      • 5.5.2.1. Plant engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. Farm Animals Engineering
      • 5.5.3.1. Farm animals engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. CRISPR-based Gene Editing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global CRISPR-based Gene Editing Market End Use Movement Analysis
  • 6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Target disease prevalence
      • 7.4.2.4. Regulatory framework
      • 7.4.2.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Target disease prevalence
      • 7.4.3.4. Regulatory framework
      • 7.4.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Target disease prevalence
      • 7.4.4.4. Regulatory framework
      • 7.4.4.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Target disease prevalence
      • 7.5.2.4. Regulatory framework
      • 7.5.2.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Target disease prevalence
      • 7.5.3.4. Regulatory framework
      • 7.5.3.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Target disease prevalence
      • 7.5.4.4. Regulatory framework
      • 7.5.4.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Target disease prevalence
      • 7.5.5.4. Regulatory framework
      • 7.5.5.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Target disease prevalence
      • 7.5.6.4. Regulatory framework
      • 7.5.6.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Target disease prevalence
      • 7.5.7.4. Regulatory framework
      • 7.5.7.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Target disease prevalence
      • 7.5.8.4. Regulatory framework
      • 7.5.8.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Target disease prevalence
      • 7.5.9.4. Regulatory framework
      • 7.5.9.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Target disease prevalence
      • 7.6.2.4. Regulatory framework
      • 7.6.2.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Target disease prevalence
      • 7.6.3.4. Regulatory framework
      • 7.6.3.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Target disease prevalence
      • 7.6.4.4. Regulatory framework
      • 7.6.4.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Target disease prevalence
      • 7.6.5.4. Regulatory framework
      • 7.6.5.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Target disease prevalence
      • 7.6.6.4. Regulatory framework
      • 7.6.6.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Target disease prevalence
      • 7.6.7.4. Regulatory framework
      • 7.6.7.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Target disease prevalence
      • 7.7.2.4. Regulatory framework
      • 7.7.2.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Target disease prevalence
      • 7.7.3.4. Regulatory framework
      • 7.7.3.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Target disease prevalence
      • 7.8.2.4. Regulatory framework
      • 7.8.2.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Target disease prevalence
      • 7.8.3.4. Regulatory framework
      • 7.8.3.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Target disease prevalence
      • 7.8.4.4. Regulatory framework
      • 7.8.4.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Target disease prevalence
      • 7.8.5.4. Regulatory framework
      • 7.8.5.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Revvity, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product/Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Danaher Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product/Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. GenScript
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product/Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product/Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Thermo Fisher Scientific, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product/Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Tocris Bioscience
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product/Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. OriGene Technologies, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product/Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Bio-Rad Laboratories
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product/Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Bio-Techne
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product/Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. New England Biolabs, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product/Service benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global CRISPR-based gene editing market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 6 North America CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 8 North America CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S. CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 11 U.S. CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 14 Canada CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 17 Mexico CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 21 Europe CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 UK CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 24 UK CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 25 UK CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Germany CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 27 Germany CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 28 Germany CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 France CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 30 France CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 31 France CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 33 Italy CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 36 Spain CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 39 Denmark CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 42 Sweden CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 45 Norway CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Japan CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 52 Japan CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 53 Japan CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 China CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 55 China CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 56 China CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 India CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 58 India CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 59 India CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Australia CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 61 Australia CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 62 Australia CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 South Korea CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 64 South Korea CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 65 South Korea CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 67 Thailand CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 71 Latin America CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 74 Brazil CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 77 Argentina CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 81 MEA CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 84 South Africa CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 90 UAE CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 93 Kuwait CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 CRISPR-based gene editing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 Porter's five force analysis
  • Fig. 17 PESTEL analysis
  • Fig. 18 CRISPR-based Gene editing market: Product & service outlook key takeaways
  • Fig. 19 CRISPR-based Gene editing market: Product & service movement analysis
  • Fig. 20 Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 CRISPR kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 CRISPR libraries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 CRISPR-based gene editing market: Application outlook key takeaways
  • Fig. 26 CRISPR-based gene editing market: Application movement analysis
  • Fig. 27 Biomedical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Therapeutic development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Genetic disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Ex vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 In vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Agricultural applications market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Plant engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Farm animals engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 CRISPR-based gene editing market: End Use outlook key takeaways
  • Fig. 41 CRISPR-based gene editing market: End Use movement analysis
  • Fig. 42 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Academic & research Institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Regional marketplace outlook, 2023 & 2033 (USD million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 U.S. CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Canada CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Mexico CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Europe CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Australia CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 South Korea CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Market participant categorization
  • Fig. 97 Company market position analysis, 2024
  • Fig. 98 Strategic framework